Skip to main content
AFJK logo

Aimei Health Technology Co., Ltd (AFJK) Stock Price & Analysis

Aimei Health Technology Co., Ltd (AFJK) — MoonshotScore 43/100 (Weak band), calculated Nov 22, 2026. Price $11.78 (-1.26%), as of the Nov 20, 2026 trading session; market cap $37.3M.

Educational signal · not a buy or sell recommendation · How to read this

$11.78 −$0.15 (-1.26%) Market Cap $37.3M

Aimei Health Technology Co., Ltd · AFJK · NASDAQ

The company aims to pursue a business combination within the biopharmaceutical, medical technology, or diagnostic services sectors.

Price as of Nov 20, 2026

Key Statistics

43 of 100

MoonshotScore v2 · Aimei Health Technology Co. (AFJK)

Weak
Business Quality Poor (18)
Financial Safety Strained (32)
Valuation Bubble (12)
Growth Durability Flat (42)
Momentum Falling (12)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

Bottom-tier quality, a strained balance sheet and an expensive valuation, though growth is only middling, and the price trend has turned against it. Business Quality: Poor; Financial Safety: Strained; Valuation: Bubble; Growth Durability: Flat; Momentum: Falling.

  • Altman Z 3.57 · Piotroski F 4

Holding back: weak fundamentals, balance-sheet strain, a rich price, weak price trend

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for AFJK (58 recorded, newest six shown)
RecordedScoreBand
43Weak
44Weak
44Weak
43Weak
43Weak
43Weak

The score was 43 in the stored Nov 21, 2026 snapshot and remains 43 in the current publication computed Nov 22, 2026 (0); the largest pillar moves were Business Quality +1 and Momentum -1; the pillar moves offset under the sector-relative weighting, so the headline score is unchanged. This current publication is not yet represented in the immutable snapshot archive.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$11.78
Change on the day-1.26%
Market capitalisation$37.3M—
Price / earnings (trailing)426.13
Shares traded on the day9.3K

Price & events

Other perspectives

Council score for Aimei Health Technology Co. (AFJK): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

5-Factor Breakdown

Business Quality Negative
Financial Safety Weak
Valuation Negative
Growth Durability Neutral
Momentum Negative

Legends Council

4 lenses, 4 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Englander-style lens (simulated) Izzy Englander Favorable read
Klarman-style lens (simulated) Seth Klarman Unfavorable read
Moon AI lens (model) Neutral read

Read on: Nov 20, 2026

Munger's Mindset

Balance Sheet & Valuation

Financial Health Weak
Margin of Safety Fairly Valued
Profit Margin Weak
Revenue Growth Weak
Debt/Equity Strong
ROE Weak
Gross Margin Negative

Read on: Nov 20, 2026

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

The Munger lens reads the current price as fairly valued against its own estimate of value.

Readings on this page are from Nov 22, 2026, except a card that shows its own read date.

1 · What is it?

What is Aimei Health Technology Co. (AFJK), and what does it report?

Short answer

A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Aimei Health Technology Co., Ltd (AFJK) is listed on NASDAQ. The market values it at $37.3M.

3 · Financial strengths and risks

What are the financial strengths and risks for Aimei Health Technology Co. (AFJK)?

Short answer

What is holding it back is weak fundamentals, balance-sheet strain, a rich price, weak price trend. The distress and quality screens read Altman Z 3.57 · Piotroski F 4. Trailing ratios: ROA -1.4% · current ratio 0.01.

5 · Peer comparison

How does Aimei Health Technology Co. compare with its peers?

Short answer

Aimei Health Technology Co.'s score ranks 13th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
XFLH Capital Corporation (XFLH) Same industry, near in market value$10.18 Nov 20, 2026$146M64 5-pillar Nov 22, 2026
Future Vision II Acquisition Corp. (FVN) Same industry, near in market value$13.45 Nov 20, 2026$76.3M55 5-pillar Nov 22, 2026
Melar Acquisition Corp. I (MACI) Same industry, near in market value$13.30 Nov 20, 2026$127M55 5-pillar Nov 22, 2026
Westin Acquisition Corp (WSTN) Same industry, near in market value$10.25 Nov 20, 2026$82.6M52 5-pillar Nov 22, 2026
GP-Act III Acquisition Corp. (GPAT) Same industry, near in market value$11.50 Nov 20, 2026$114M52 5-pillar Nov 22, 2026
Bullpen Parlay Acquisition Company (BPAC) Same industry, near in market value$10.30 Nov 20, 2026$76.1M51 5-pillar Nov 22, 2026
Wintergreen Acquisition Corp. (WTG) Same industry, near in market value$10.73 Nov 20, 2026$78.7M51 5-pillar Nov 22, 2026
Texas Ventures Acquisition III Corp (TVA) Same industry, near in market value$10.68 Nov 20, 2026$131M51 5-pillar Nov 22, 2026
Cantor Equity Partners VI, Inc. Class A Ordinary Shares (CEPS) Same industry, near in market value$10.11 Nov 20, 2026$148M51 5-pillar Nov 22, 2026
SIM Acquisition Corp. I (SIMA) Same industry, near in market value$10.81 Nov 20, 2026$88.9M50 5-pillar Nov 22, 2026
Origin Investment Corp I (ORIQ) Same industry, near in market value$10.45 Nov 20, 2026$94.4M49 5-pillar Nov 22, 2026
Andretti Acquisition Corp. II (POLE) Same industry, near in market value$10.78 Nov 20, 2026$148M48 5-pillar Nov 22, 2026
Aimei Health Technology Co. (AFJK) — this page$11.78$37.3M43

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

The records behind this page

Insider activity

Form 4 records via FMP · Most recent available transactions

Transactions
3
Identified insiders
2
Purchases
2
Sales
1
Other transactions
0

Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held AFJK in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported AFJK in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

Common Questions About AFJK

These answers are editorial: 1 of these 9 answers is drawn from the AFJK research dossier (written May 9, 2026 by gemini-2.0-flash); the other 8 are question templates that restate figures shown above. Figures in this section are not part of the source register.

What does the MoonshotScore mean for AFJK?

AFJK carries the MoonshotScore stated above — the Weak band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.

Is AFJK a good stock to buy?

Stock Expert AI does not rate AFJK buy, sell or hold. Aimei Health Technology Co., Ltd carries a MoonshotScore, in the Weak band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.

What is the AFJK stock price today?

The last price recorded for Aimei Health Technology Co., Ltd (AFJK), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What does Aimei Health Technology Co., Ltd do?

Aimei Health Technology Co., Ltd operates as a special purpose acquisition company (SPAC). It was formed to raise capital through an initial public offering (IPO) with the intention of acquiring or merging with a private company.

What are the key factors to evaluate for AFJK?

Aimei Health Technology Co., Ltd (AFJK) holds a MoonshotScore in the low range. To weigh it, start with the trailing P/E under Price & valuation on this page. Their ability to conduct thorough due diligence and negotiate favorable terms will be crucial for the success of any acquisition. Not financial advice.

How frequently does AFJK data refresh on this page?

AFJK's price is the last quote we recorded, from the Nov 20, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.

What has driven AFJK's recent stock price performance?

Aimei Health Technology Co., Ltd (AFJK) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Access to capital through public markets. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider AFJK overvalued or undervalued right now?

The trailing P/E of Aimei Health Technology Co., Ltd (AFJK) is listed under Price & valuation on this page. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Can I buy fractional shares of AFJK?

Fractional-share availability for Aimei Health Technology Co., Ltd (AFJK) depends on your brokerage, account and supported securities. Check the broker's current eligibility, minimums and fees before placing an order.

Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 9, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 11 figures on this page — 6 from Financial Modeling Prep (FMP), 3 with no recorded source and 2 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.